Senti Biosciences, Inc. (SNTI)

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Next-generation Cell and Gene Therapies	2.56M	Log In	Log In
Next-generation Cell and Gene Therapies Growth	-40.25%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	2.56M	Log In	Log In
United States Growth	-40.25%	Log In	Log In